NASDAQ:ATOS

Atossa Genetics Stock News

Healthcare > Biotechnology

Buy ATOS

*Your capital is at risk

$4.70

-0.150 (-3.09%)

At Close: Jun 03, 2026

Physician-Scientist Steven Quay Provides Open Letter Response to WHO Report: Five Undisputed Facts Support the Laboratory Origin of the COVID Virus

09:40am, Tuesday, 30'th Mar 2021

SEATTLE, March 30, 2021 /PRNewswire/ -- An Open Letter concerning the WHO Report was published today by Dr. Steven Quay, M.D., PhD., CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS), entitled, "To Stop

ATOS Stock Price Increased Over 23% Intraday: Why It Happened

10:16am, Thursday, 11'th Mar 2021

The stock price of Atossa Therapeutics Inc (NASDAQ: ATOS) has increased by over 23% during intraday trading. This is why it happened.

Atossa Therapeutics Announces Receipt of FDA Safe to Proceed Letter for Treatment of an Ovarian Cancer Patient with Oral Endoxifen Under Expanded Access Pathway

09:30am, Thursday, 11'th Mar 2021

SEATTLE, March 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signif

Atossa Therapeutics' COVID-19 Nasal Spray Safe In Early-Stage Study

11:15am, Thursday, 25'th Feb 2021

Atossa Therapeutics Inc (NASDAQ: ATOS) announces final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently

Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Accomplishments and Strategy for 2021

09:30am, Wednesday, 10'th Feb 2021

SEATTLE, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signifi

Why Atossa Therapeutics Stock Soared Today

03:15pm, Thursday, 04'th Feb 2021

Investors are excited about the potential of the biotech's experimental breast cancer treatment.

ATOS Stock: 8 Things for Investors to Know About Atossa Therapeutics as It Soars Thursday

02:16pm, Thursday, 04'th Feb 2021

Atossa Therapeutics (ATOS) stock is on the rise with heavy trading Thursday after announcing some positive breast cancer news. The post ATOS Stock: 8 Things for Investors to Know About Atossa Therapeu

Atossa Therapeutics Announces Two-Year Update of FDA-Approved Expanded Access Treatment with Endoxifen

09:30am, Wednesday, 03'rd Feb 2021

SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific

Atossa Therapeutics' Phase 2 Endoxifen Breast Cancer Study Produces Substantially Positive Results Allowing Study to be Halted Early

09:30am, Tuesday, 02'nd Feb 2021

SEATTLE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific

Atossa Therapeutics Receives $21 Million from Recent Exercises of Outstanding Warrants

09:30am, Friday, 29'th Jan 2021

SEATTLE, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific

Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S.

09:30am, Monday, 25'th Jan 2021

SEATTLE, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by